Tag: Vericel
Vericel Corporation Announces Exercise of Underwriters’ Over-Allotment Option and Closing of...
CAMBRIDGE, Mass., Dec. 21, 2016 - Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious...
